JFLLIFE

JFL Life Sciences Share Price

 

 

Start SIP in JFLLIFE

Start SIP

Performance

  • Low
  • ₹12
  • High
  • ₹12
  • 52 Week Low
  • ₹10
  • 52 Week High
  • ₹22
  • Open Price₹12
  • Previous Close₹11
  • Volume12,000
  • 50 DMA₹11.80
  • 100 DMA₹12.85
  • 200 DMA₹14.58

Investment Returns

  • Over 1 Month + 1.27%
  • Over 3 Month -11.11%
  • Over 6 Month -15.79%
  • Over 1 Year -41.32%

Smart Investing Starts Here Start SIP with JFL Life Sciences for Steady Growth!

Invest Now

JFL Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 9.5
  • PEG Ratio
  • -0.6
  • Market Cap Cr
  • 40
  • P/B Ratio
  • 0.9
  • Average True Range
  • 0.45
  • EPS
  • 1.46
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.38
  • RSI
  • 56.95
  • MFI
  • 68.14

JFL Life Sciences Financials

JFL Life Sciences Technicals

EMA & SMA

Current Price
₹12.00
+ 0.55 (4.8%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹11.22
  • 50 Day
  • ₹11.80
  • 100 Day
  • ₹12.85
  • 200 Day
  • ₹14.58

Resistance and Support

11.98 Pivot Speed
  • R3 12.07
  • R2 12.03
  • R1 12.02
  • S1 11.97
  • S2 11.93
  • S3 11.92

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Jfl Life Sciences has an operating revenue of Rs. 80.06 Cr. on a trailing 12-month basis. An annual revenue growth of 74% is outstanding, Pre-tax margin of 7% is okay, ROE of 10% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 21 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 176 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

JFL Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-29 Quarterly Results & Others To consider other business matters. issue in the ratio of 2:1 of Rs. 10/-.
2025-11-11 Quarterly Results & Others To consider other business matters. issue in the ratio of 2:1 of Rs. 10/-.
2025-09-01 Others To consider other business matters. issue in the ratio of 2:1 of Rs. 10/-.
2025-08-11 Quarterly Results & Others To consider other business matters. issue in the ratio of 2:1 of Rs. 10/-.
2025-05-19 Audited Results
Date Purpose Remarks
2024-09-24 Bonus Rs.0.00 issue in the ratio of 2:1 of Rs. 10/-.

JFL Life Sciences F&O

JFL Life Sciences Shareholding Pattern

67.47%
28.54%
3.99%

About JFL Life Sciences

  • NSE Symbol
  • JFLLIFE
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Smiral Ashwinkumar Patel
  • ISIN
  • INE0LA901015

Similar Stocks to JFL Life Sciences

JFL Life Sciences FAQs

JFL Life Sciences share price is ₹12 As on 11 February, 2026 | 18:16

The Market Cap of JFL Life Sciences is ₹39.6 Cr As on 11 February, 2026 | 18:16

The P/E ratio of JFL Life Sciences is 9.5 As on 11 February, 2026 | 18:16

The PB ratio of JFL Life Sciences is 0.9 As on 11 February, 2026 | 18:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23